Project description
A platform for efficient collaboration on neurodegenerative disorders
An estimated 165 million Europeans are living with a brain disorder, including Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. The Innovative Medicines Initiative, Europe’s biggest public and private collaboration in life sciences, has launched research projects to better understand and treat these disorders. To connect these projects, the EU-funded NEURONET project is developing a platform for mutual awareness and collaboration. It aims to help scientists identify gaps in research and make findings more visible. Among the project’s numerous goals is to map initiatives, assets and partnerships, assess impact, detect synergies and facilitate collaborations. Grounded on systems leadership approaches, it will detect opportunities for further research and transferable best practices that help accelerate future projects and make them more efficient.
Fields of science
Programme(s)
Funding Scheme
IMI2-CSA - Coordination & support actionCoordinator
28006 Madrid
Spain
See on map
Participants (9)
M1 4BT Manchester
See on map
1417 Luxembourg
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2340 Beerse
See on map
RG21 4FA Basingstoke
See on map
4070 Basel
See on map
Participation ended
WC2B 4AE London
91380 Chilly Mazarin
See on map
SW1V 1EJ London
See on map
8152 Glattpark
See on map